Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

NCT06953960

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Southern California /ID# 272414 Los Angeles, California, United States
  • Yale University School of Medicine /ID# 272447 New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute /ID# 271846 Boston, Massachusetts, United States
  • University of Michigan Health System - Ann Arbor /ID# 271536 Ann Arbor, Michigan, United States
View all 48 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

NCT07416604

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Center for Inherited Blood Disorders Orange, California, United States
  • Innovative Hematology, Inc. Indianapolis, Indiana, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • Washington Center for Bleeding Disorders Seattle, Washington, United States
View Trial Details
Recruiting

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

NCT07359859

Conditions
Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

NCT07012044

Conditions
Acute Myeloid Leukemia Post Cytotoxic Therapy, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • C S Mott Children's Hospital Ann Arbor, Michigan, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
View Trial Details

Related conditions